| Dr Dennis C Hammond, MD | |
|
4070 Lake Dr Se, Suite 202, Grand Rapids, MI 49546-8294 | |
| (616) 464-4420 | |
| (616) 464-4354 |
| Full Name | Dr Dennis C Hammond |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 39 Years |
| Location | 4070 Lake Dr Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508808536 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 4301087811 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Breast And Body Contouring Pc | 7315920402 | 3 |
News Archive
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
It may be possible to predict the severity of hearing loss for children diagnosed with enlarged vestibular aqueduct, according to a new study published in JAMA-Otolaryngology-Head & Neck Surgery.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
› Verified 8 days ago
| Entity Name | Spectrum Health Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558407189 PECOS PAC ID: 8921904764 Enrollment ID: O20040120000997 |
News Archive
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
It may be possible to predict the severity of hearing loss for children diagnosed with enlarged vestibular aqueduct, according to a new study published in JAMA-Otolaryngology-Head & Neck Surgery.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
› Verified 8 days ago
| Entity Name | Center For Breast & Body Contouring Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194755306 PECOS PAC ID: 7315920402 Enrollment ID: O20040610000188 |
News Archive
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
It may be possible to predict the severity of hearing loss for children diagnosed with enlarged vestibular aqueduct, according to a new study published in JAMA-Otolaryngology-Head & Neck Surgery.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis C Hammond, MD 4070 Lake Dr Se, Suite 202, Grand Rapids, MI 49546-8294 Ph: (616) 464-4420 | Dr Dennis C Hammond, MD 4070 Lake Dr Se, Suite 202, Grand Rapids, MI 49546-8294 Ph: (616) 464-4420 |
News Archive
Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has achieved the CAQH® Committee on Operating Rules for Information Exchange (CORE®) Phase II Certification for its Phoenix Processing System.
It may be possible to predict the severity of hearing loss for children diagnosed with enlarged vestibular aqueduct, according to a new study published in JAMA-Otolaryngology-Head & Neck Surgery.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, an estimated 18 percent of pediatric patients in a University of North Carolina-based study were at-risk for sleep-related breathing disorders (SRBD). Importantly, pediatric risk was not associated with any demographic or craniofacial characteristics, as it is in adults, making it difficult to detect.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Currently no treatment option is available for five percent of patients suffering from chronic myelogenous leukemia, since they have developed resistance to conventional medications. Prof. Stephan Grzesiek's group at the Biozentrum of the University of Basel, in collaboration with Dr. Wolfgang Jahnke and colleagues from Novartis, has investigated the combined action of two different compounds against this form of leukemia.
› Verified 8 days ago
Mr. Steven Loren Ringler, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 220 Lyon St Nw, Ste 700, Grand Rapids, MI 49503 Phone: 616-451-4500 Fax: 616-451-9077 | |
Dr. Robyn Sackeyfio, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 E Paris Ave Se, Suite 221, Grand Rapids, MI 49546 Phone: 616-222-0770 | |
Mark R Dehaan, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1111 Leffingwell Ave Ne, Suite 200, Grand Rapids, MI 49525 Phone: 616-459-7101 Fax: 616-464-6170 | |
Dr. David R Alfonso, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 220 Lyon St Nw, Suite 700, Grand Rapids, MI 49503 Phone: 616-451-4500 Fax: 616-451-9077 | |
Reece Moore, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 866-989-7999 | |
Justin Edward Markel, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 330 Barclay Ave Ne Ste 104, Grand Rapids, MI 49503 Phone: 616-391-6243 | |
Arminder Singh Kaura, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 221 Michigan St Ne Ste 300, Grand Rapids, MI 49503 Phone: 616-391-1909 Fax: 616-391-8612 |